7 articles with Xeltis
Xeltis, a clinical-stage company with the most advanced polymer-based restorative cardiovascular devices, announced that it has started the first-ever pivotal trial for a synthetic restorative pulmonary valve.
The funding round was led by a global strategic investor with participation from venture capital fund Ysios Capital and a number of large private investors.
Xeltis' Technology For Natural Heart Valve Restoration Featured As The Future Of Valve Therapy At EuroPCR
Xeltis Release: First Heart Valve That Enables Cardiovascular Restoration Successfully Implanted in Three Patients in "Xplore-I" Clinical Trial
Xeltis Release: Pediatric Feasibility Study Results Set Stage For Clinical Trial Of World’s First Bioabsorbable Heart Valve Enabling Endogenous Tissue Restoration